Quest PharmaTech Inc. - Product Pipeline Review – 2015 Now Available at iData Insights Quest PharmaTech Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct s, Quest PharmaTech Inc. - Product Pipeline Review - 2015, provides an overview of the Quest PharmaTech Inc. s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Quest PharmaTech Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-inclass products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Quest PharmaTech Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Quest PharmaTech Inc.s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Quest PharmaTech Inc.s pipeline products Reasons to buy - Evaluate Quest PharmaTech Inc.s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Quest PharmaTech Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Quest PharmaTech Inc. s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Quest PharmaTech Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Quest PharmaTech Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners 1
with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Quest PharmaTech Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues Browse Complete Report with TOC @ http://www.idatainsights.com/reports-landingpage.php?id=124228/quest-pharmatech-inc-product-pipeline-review-2015 To Get Sample Copy of Report visit @ http://www.idatainsights.com/reports-landingpage.php?id=124228/quest-pharmatech-inc-product-pipeline-review-2015 Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Quest PharmaTech Inc. Snapshot 5 Quest PharmaTech Inc. Overview 5 Key Information 5 Key Facts 5 Quest PharmaTech Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Quest PharmaTech Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Quest PharmaTech Inc. - Pipeline Products Glance 12 Quest PharmaTech Inc. - Clinical Stage Pipeline Products 12 Phase II Products/Combination Treatment Modalities 12 Phase I Products/Combination Treatment Modalities 13
2
Quest PharmaTech Inc. - Early Stage Pipeline Products 14 Preclinical Products/Combination Treatment Modalities 14 Quest PharmaTech Inc. - Drug Profiles 15 oregovomab 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 SL-052 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 AR-20.5 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Monoclonal Antibody To Target MUC1 for Oncology 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Monoclonal Antibody to Antagonize HER2/neu for Breast Cancer 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Monoclonal Antibody to Inhibit PSA for Prostate Cancer 23 3
Product Description 23 Mechanism of Action 23 R&D Progress 23 Quest PharmaTech Inc. - Pipeline Analysis 24 Quest PharmaTech Inc. - Pipeline Products by Target 24 Quest PharmaTech Inc. - Pipeline Products by Route of Administration 25 Quest PharmaTech Inc. - Pipeline Products by Molecule Type 26 Quest PharmaTech Inc. - Pipeline Products by Mechanism of Action 27 Quest PharmaTech Inc. - Recent Pipeline Updates 28 Quest PharmaTech Inc. - Discontinued Pipeline Products 30 Discontinued Pipeline Product Profiles 30 ACP-2127 30 oregovomab 30 Quest PharmaTech Inc. - Locations And Subsidiaries 31 Head Office 31 Appendix 32 Methodology 32 Coverage 32 Secondary Research 32 Primary Research 32 Expert Panel Validation 32 Contact Us 32 Disclaimer 33
4
Read More http://www.idatainsights.com/reports-landing-page.php?id=124228/quest-pharmatech-incproduct-pipeline-review-2015 About Us: iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line. ContactUs: iData Insights Tel: 1-866-237-2965 Web: http://www.idatainsights.com Email: info@idatainsights.com About iData Insights We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects
5